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TECHNICAL NOTE
Aluminum leakage from REDY sorbent cartridge
WARREN B. SHAPIRO, THEODORE P. SCHILB, CLARENCE L. WALTROUS, STEVEN R. LEVY,
and JEROME G. PORUSH
Division of Nephrology and Hypertension, Department of Medicine, The Brookdale Hospital Medical Center, Brooklyn, New York
Although hemodialysis (HD) is able to keep patients with
endstage renal disease (ESRD) alive, it does not completely
reverse many of the sequellae of chronic renal failure. Hemofil-
tration (HF) based on convective transport principles similar to
that of the natural kidney has been shown to have important
advantages over HD. Studies have demonstrated that HF can
result in: stabilization of blood pressure during treatment [1];
better control of hypertension between treatments [2]; improve-
ment in uremic symptomatology [3]; improvement in uremic
neuropathy [4]. One important drawback to HF as practiced
today is the need to replace the large quantities of ultrafiltrate
produced by an equal amount of sterile, pyrogen-free electro-
lyte solution. This procedure is costly and requires precise
monitoring to avoid surfeits and deficits. To overcome this
major drawback of HF, we examined a method of recycling
ultrafiltrate by cleansing it with a sorbent system.
This sorbent recycling of ultrafiltrate (SRUF) system utilizes
an Amicon Diafilter (Amicon Corporation, Lexington, Massa-
chusetts) as the ultrafilter and a REDY sorbent cartridge (RSC)
(Organon Teknika Corporation, Oklahoma City, Oklahoma) as
the sorbent system. The standard (3150) RSC which was to be
used in our SRUF system has been in use since 1974 to
regenerate dialysis fluid. It is composed of the following layers
from bottom to top (the direction of fluid flow): (1) purification
layer consisting of activated carbon, alumina (aluminum oxide)
and hydrated zirconium oxide in the chloride form to remove
heavy metals, bleach, formaldehyde, and other trace materials
which could adversely effect the urease layer; (2) urease
stabilized with alumina to degrade urea by converting it into
ammonium carbonate; (3) zirconium phosphate (ZP), a cation
exchanger present in both the sodium (Na-ZP) and hydrogen
(H-ZP) forms, which exchanges these cations for ammonium
produced from urea breakdown and also for calcium, magne-
sium, and potassium present in the ultrafiltrate; (4) hydrated
zirconium oxide in the acetate form (H-ZO-AC) mixed with
alumina to remove phosphate and fluoride; (5) activated carbon
which removes creatinine and other organic compounds. The
alumina in the RSC was first thought to be inert. However,
aluminum has been incriminated in the development of dialysis
osteomalacia and dialysis dementia after prolonged hemodialy-
sis treatment with the RSC [5].
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Unlike HD where there is a membrane separating the RSC
from the circulation, the SRUF procedure utilizes the RSC to
cleanse ultrafiltrate which is then returned directly to the blood.
Thus, any aluminum leaking from the RSC would have direct
access to the blood. Early work from Shaldon et al [6] indicated
that the RSC, when used to cleanse ultrafiltrate, leaks alumi-
num in significant amounts but that this problem could be
eliminated by passing the post-RSC fluid through an Amicon
Diafilter to remove particulate matter. Later work from this
same group indicated that patients treated chronically with a
system in which an RSC was used to cleanse ultrafiltrate
developed severe bone disease and elevated blood aluminum
levels despite passage of ultrafiltrate through a second steriliz-
ing Amicon Diafilter [7].
Therefore, prior to utilizing the SRUF system clinically, we
examined the RSC for aluminum leakage in vitro and in vivo in
dogs. Our results indicate that aluminum leaks from the stan-
dard RSC in amounts that could be toxic and that it is not
removed by an Amicon Diafilter. The problem was corrected,
however, by producing a modified RSC in which the alumina
filler was removed. The modified RSC produced by Organon
Teknika and now marketed as the 3160 cartridge (with United
States Food and Drug Administration approval) is composed of
the following layers: (1) purification layer made of carbon and
hydrated zirconium oxide in the chloride form but without
alumina; (2) urease stabilized with alumina; (3) ZP in both the
Na-ZP and H-ZP forms; (4) H-ZO-AC without alumina; (5)
activated carbon. All layers in the 3160 RSC have the same
purpose as in the 3150. The volume formally occupied by the
alumina has been filled by a polystyrene spacer.
Methods. For all protocols the 3150 (standard) and 3160
(modified) RSC were used. Each RSC was prerinsed twice. The
first prerinse was used to titrate the H-ZP/Na-ZP buffer pair
toward the basic side and consisted of 4.5 liters of 190 mrvi
sodium bicarbonate which was pumped through the RSC at a
rate of 100 mi/mm until 3 liters were collected in a graduated
cylinder (the dead space volume of the RSC is 1.5 liters). The
second prerinse was utilized so that the initial sodium concen-
tration post-RSC at the start of a study would be uniform and at
a physiologic level and consisted of 3 liters of 120 m sodium
chloride pumped through the RSC in the same manner as the
first prerinse.
Control studies. To determine whether or not differences in
the composition between artificial and uremic dog ultrafiltrate
would lead to alterations in the measurement of aluminum, we
sent samples of both ultrafiltrates for aluminum determination
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Table 1. Comparison of aluminum determinations in deionized water,
artificial, and uremic ultrafiltrate (jsg/liter)
Artificial Uremic dog
ultrafiltrate ultrafiltrate
Aluminum Deionized water plus plus
standard plus standard standard standard'
0 0 0 4
13 13 14 17 (13)
26 27 28 28 (24)
52 57 59 68 (64)
104 113 113 117(113)
a Numbers shown in parentheses represent values
subtracting the initial aluminum concentration.
corrected by
Fig. 1. Schematic diagram of the apparatus used for in vitro aluminum
leakage studies. Samples were taken for aluminum analysis from the
following sites: A, the feed tank; B, distal to the RSC; C, collecting
tanks distal to the Amicon Diafilters.
Fig. 2. Schematic diagram of the SRUF system used for in vivo
aluminum leakage studies. Samples were taken for aluminum analysis
from the following sites: A, ultrafiltrate post-Amicon Diafilter; B,
ultrafiltrate post-RSC; C, ultrafiltrate poststerilizing Amicon Diafilter;
D, blood post-Amicon Diafilter combined with cleansed ultrafiltrate
prior to return to the animal. The numbers are: 1, Amicon Diafilter (0.5
m2); 2, REDY sorbent cartridge; 3, infusate; 4, sterilizing Amicon (0.5
m2); 5, fluid removal tank.
by fiameless atomic absorption (courtesy of Dr. A. Alirey,
University of Colorado) [8, 91. These and all other samples were
stored and shipped in aluminum-free plastic containers and
analyzed in an identical manner. Uremic dog ultrafiltrate was a
Table 2. Aluminum determinations (jig/liter SEM) during SRUF
utilizing the standard RSCa
Time, mm Site A Site B Site C
In vitro (N = 4)
0 14 8 94 33t 81 37b
60 4± 1 30± 75 19± 6b
120 3 1 41 9h 30 5"
180 5 1 30 12" 37 3"
In vivo (N = 13)
0 11± 5 28± 6 26± 7
180 33 13 231 106" 192 68"
Abbreviations: RSC, REDY sorbent cartridge; SRUF, sorbent recy-
cling of ultrafiltrate.
a For location of in vitro sites see Figure 1; for location of in vivo sites
see Figure 2.
P < 0.005 vs. A.
pooled sample (six animals) postmodified RSC at 180 mm from
site C (Fig. 2). At the laboratory the samples were subdivided
into 5 aliquots to which one of five aluminum standard solutions
was added. The standards contained aluminum at the concen-
trations listed in Table 1. Controls, consisting of deionized
water plus the same aluminum standards, were analyzed togeth-
er with the ultrafiltrate samples.
In vitro studies. Four standard and four modified RSCs were
studied simultaneously using the in vitro system depicted
schematically in Figure 1. Each of the prerinsed RSCs was
perfused with 25 liters of an artificial ultrafiltrate containing Na
150, Cl 137, K 7, HCO3 20, and urea 18 mM/liter pumped from
the feed tank at a rate of 120 mi/mm. Samples were taken at
times and sites as indicated in Tables 2 and 3 and Figure 1 for
aluminum analysis as described above. Site A is the feed tank,
site B is post-RSC and site C is the collecting tank distal to the
Amicon Diafilter used to remove particulate matter.
In vivo studies. Figure 2 depicts schematically the SRUF
system used for these studies. Twenty dogs were made uremic
by bilateral ureteral ligation 2 days prior to the experiment
which consisted of 180 mm of SRUF at an UF flow rate of 50
ml/min with the RSC prerinsed as in the in vitro studies. The
only difference between in vitro and in vivo studies was that the
SRUF system (blood and ultrafiltrate lines, Amicon Diafilters
and degassing filters) were rinsed with saline and air purged
from the system. Calcium and magnesium are removed from the
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Collecting tanks
In vitro (N = 4)
Time, mm
0
60
180
In vivo (N = 7)
Time, mm
0
90
120
180
Site A5±0
5±05±0
Arterial
plasma
3.0 0.7
2.7 0.6
4.1 1.1
6.9 1.8
Site B
4±1
4±1
6±3
Site A
3.0 1.2
2.8 0.9
4.5 1.7
2.0 0.0
Site C
2±1
3±1
3±1
Site B
3.5 1.0
2.0 0.0
2.4 0.5
8.0 2.4
Site D
3.0 0.6
3.8 1.7
4.0 1.2
5.3 1.3
ultrafiltrate by the RSC and were replaced with 3 mEq/liter Ca
and 1 mEq/liter Mg at a point distal to the RSC (see 3 in Fig. 2).
Samples for aluminum analysis were taken at the times and sites
indicated in Tables 2 and 3 and Figure 2. Site A (ultrafiltrate
post-Amicon Diafilter), site B (ultrafiltrate post-RSC), site C
(ultrafiltrate poststerilizing Amicon which is used to remove
particulate matter) and site D (blood post-Amicon Diafilter
combined with cleansed ultrafiltrate prior to return to the
animal). Site D, like site C, will reflect aluminum leakage from
the RSC. All results are expressed as the mean SD. Statistical
analysis was performed by Student's t test or analysis of
variance where appropriate.
Results. Table 1 summarizes the results of the control stud-
ies. It can be seen that deionized water, artificial ultrafiltrate
which was made with tap water and the uremic dog ultrafiltrate
show similar concentrations of aluminum after the addition of
the aluminum-containing standard solutions.
Table 2 summarizes the results of the in vivo and in vitro
studies with the standard RSC. Aluminum levels did not vary
significantly with time in the in vitro studies but were signifi-
cantly higher at B and C (both sites distal to the RSC) compared
to A (pre-RSC). There were no significant changes in aluminum
levels when the fluid was passed through an Amicon Diafilter (B
vs. C). Aluminum concentration at the start of the in vivo
SRUF procedure (zero time) was similar at all sites. At 180 mm
(the end of the procedure) aluminum levels at B and C had
increased markedly. There were no significant changes in
aluminum levels when the ultrafiltrate was passed through the
sterilizing Amicon Diafilter (C vs. B).
The results of in vivo and in vitro tests with the modified RSC
are summarized in Table 3. Aluminum did not leak from this
RSC in physiologically significant quantities. At all times in the
in vitro studies (0, 60, and 180 mm) aluminum levels were at the
lower limits of the sensitivity of the test. Aluminum levels in the
in vivo studies were measured in arterial plasma, sites A, B, and
D at 0, 90, 120, and 180 mm. At no time were the mean
aluminum levels greater than 10 sgIIiter, the permissible limit of
aluminum concentration for water used to prepare dialysate
[101.
Discussion. The data demonstrate that the standard RSC
leaks toxic amounts of aluminum when used as a sorbent
cleanser in an ultrafiltration system designed to recycle ultrafil-
trate rather than discard it. On the basis of this finding, a
modified RSC has been designed in which aluminum was
removed from points distal to the urease layer. When tested in
the same systems in which the standard RSC leaked large
amounts of aluminum, aluminum levels remained at the lower
limit of detection making this RSC sorbent system acceptable
for application to our SRUF system and more acceptable for
use in cleansing dialysate in hemodialysis as well.
An interesting observation in the present experiments is that
the aluminum leakage was significantly greater when the stan-
dard RSC was exposed to uremic dog plasma than when
exposed to an artificial ultrafiltrate (Table 2). The similar Al
levels in deionized water, artificial and uremic dog ultrafiltrate
in the control studies suggest that the difference between
artificial and uremic dog ultrafiltrate aluminum concentration is
not an artifact of analysis. It is possible that the uremic dog
ultrafiltrate compromised the integrity of the RSC leading to its
dissolution. The particles of aluminum (as alumina) released
could then have been responsible for the elevated aluminum
levels. This possibility is unlikely because we have inserted a
second (sterilizing) Amicon distal to the RSC which traps any
particles released from the RSC. We have examined the post-
RSC, post-Amicon uremic dog ultrafiltrate under the micro-
scope on numerous occasions and at no time have particles
been seen distal to the sterilizing Amicon (Shapiro, Schilb,
Waltrous, Levy, and Porush, personal observations). Another
possible explanation for the difference is that uremic dog
ultrafiltrate may result in greater changes in pH than artificial
ultrafiltrate leading to solubilization of the alumina. Although
we cannot measure the internal pH of the RSC there was no
difference in the post-RSC pH between artificial and uremic dog
ultrafiltrate (Shapiro, Schilb, Waltrous, Levy, and Porush,
personal observations). Finally, it is possible that some compo-
nent or property of uremic dog ultrafiltrate which passes
through the Amicon Diafilters promotes solubilization of the
alumina in the RSC. This possibility appears most likely but
was not addressed in the present experiments.
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Table 3. Aluminum determinations (g/liter sEat) during SRUF utilizing the modified RSCa
a For location of in vitro sites see Figure 1; for location of in vivo sites see Figure 2. Abbreviations are in Table 2.
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